The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ‘cure’

European Journal of Endocrinology - Tập 152 Số 3 - Trang 379-387 - 2005
P. Nomikos1, Michael Buchfelder1, Rudolf Fahlbusch1
1Department of Neurosurgery, University of Erlangen-Nürnberg, Erlangen, Germany

Tóm tắt

Background and aim: The aim of this study was to illustrate the present role of transsphenoidal surgery as primary therapy in GH-secreting adenomas, and to compare the results concerning control of disease with previous series using older criteria of cure.

Method: We report on a consecutive series of 688 acromegalic patients treated over a time period of 19 years. Biochemical cure was defined as normalisation of basal GH level, suppression of GH levels to below 1 ng/ml during an oral glucose load and normalisation of IGF-I levels. Of the 506 patients undergoing primary transsphenoidal surgery, a total of 57.3% postoperatively fulfilled the criteria used.

Results: The rate of biochemical ‘cure’ correlated with the magnitude of the initial GH levels, the tumour size and invasion. The overall complication rate was below 2%. Mortality in this series was 0.1% (1 of 688). During a follow-up period of 10.7 years only two recurrences (0.4%) occurred. However, in the patients treated by transcranial surgery and by repeat surgery the cure rate was found to be relatively low (5.2 and 21.3% respectively).

Conclusions: These data suggest that surgery remains with very few exceptions the primary treatment of acromegaly for (i) a high cure rate, (ii) low morbidity, (iii) low recurrence rate and (iv) immediate decline of GH. Based on current criteria of cure, recurrences are uncommon. However, cure by surgery alone is improbable in patients harbouring extended, invasive tumours with high secretory activity, in whom further adjuvant treatment is mandatory.

Từ khóa


Tài liệu tham khảo

Beauregard, 2003, Clinical endocrinology, 58, 86, 10.1046/j.1365-2265.2003.01679.x

Orme, 1998, Journal of Clinical Endocrinology & Metabolism, 83, 2730, 10.1210/jc.83.8.2730

Rajasoorya, 1994, Clinical endocrinology, 41, 95, 10.1111/j.1365-2265.1994.tb03789.x

Swearingen, 1998, Journal of Clinical Endocrinology & Metabolism, 83, 3419, 10.1210/jc.83.10.3419

BATES, 1993, QJM, 86, 293

Ayuk, 2002, Journal of Clinical Endocrinology & Metabolism, 87, 4142, 10.1210/jc.2001-011913

Bevan, 2002, Journal of Clinical Endocrinology & Metabolism, 87, 4554, 10.1210/jc.2001-012012

Newman, 1999, Endocrinology and metabolism clinics of North America, 28, 171, 10.1016/S0889-8529(05)70062-1

Newman, 1995, Journal of Clinical Endocrinology & Metabolism, 80, 2768, 10.1210/jc.80.9.2768

Trainer, 2000, New England Journal of Medicine, 342, 1171, 10.1056/NEJM200004203421604

Melmed, 2002, Journal of Clinical Endocrinology & Metabolism, 87, 4054, 10.1210/jc.2002-011841

Giustina, 2000, Journal of Clinical Endocrinology & Metabolism, 85, 526, 10.1210/jc.85.2.526

Ross, 1988, Journal of neurosurgery, 68, 854, 10.3171/jns.1988.68.6.0854

Losa, 1989, Journal of neurosurgery, 70, 561, 10.3171/jns.1989.70.4.0561

Valdemarsson, 1991, Journal of internal medicine, 230, 49, 10.1111/j.1365-2796.1991.tb00405.x

Valdemarsson, 2000, Journal of internal medicine, 247, 640, 10.1046/j.1365-2796.2000.00667.x

Fahlbusch, 1992, Endocrinology and metabolism clinics of North America, 21, 669, 10.1016/S0889-8529(18)30208-1

Tindall, 1993, Journal of neurosurgery, 78, 205, 10.3171/jns.1993.78.2.0205

Kreutzer, 2001, Journal of Clinical Endocrinology & Metabolism, 86, 4072, 10.1210/jc.86.9.4072

Freda, 1998, Journal of neurosurgery, 89, 353, 10.1097/00006123-199808000-00107

Freda, 2004, Journal of Clinical Endocrinology & Metabolism, 89, 495, 10.1210/jc.2003-031316

Peacey, 2001, Journal of Clinical Endocrinology & Metabolism, 86, 259, 10.1210/jc.86.1.259

Ahmadi, 1986, American Journal of Roentgenology, 146, 257, 10.2214/ajr.146.2.257

1996, Acta neurochirurgica, 65, 18

Sheaves, 1996, Clinical endocrinology, 45, 407, 10.1046/j.1365-2265.1996.8370847.x

Abe, 2001, European Journal of Endocrinology, 145, 137, 10.1530/eje.0.1450137

Kristof, 1999, Acta neurochirurgica, 141, 399, 10.1007/s007010050316

Arafah, 1982, Clinical endocrinology, 17, 213, 10.1111/j.1365-2265.1982.tb01583.x

ARAFAH, 1990, Journal of Clinical Endocrinology & Metabolism, 71, 323, 10.1210/jcem-71-2-323

Nelson, 1984, Journal of neurosurgery, 61, 577, 10.3171/jns.1984.61.3.0577

Arafah, 1987, The Journal of laboratory and clinical medicine, 109, 346

Davis, 1993, Journal of neurosurgery, 79, 70, 10.3171/jns.1993.79.1.0070

Abe, 1998, Neurosurgery, 42, 1013, 10.1097/00006123-199805000-00036

Kurosaki, 2003, Endocrine journal, 50, 635, 10.1507/endocrj.50.635

Ahmed, 1999, Clinical endocrinology, 50, 561, 10.1046/j.1365-2265.1999.00760.x

Lissett, 1998, Clinical endocrinology, 49, 653, 10.1046/j.1365-2265.1998.00581.x

Abosch, 1998, Journal of Clinical Endocrinology & Metabolism, 83, 3411, 10.1210/jc.83.10.3411

Gittoes, 1999, QJM, 92, 741, 10.1093/qjmed/92.12.741

Thông tin
Thông tin xuất bản

European Journal of Endocrinology

Tập 152 Số 3

379-387

Thông tin tác giả